Eduardo Dourado
Impact in
-
- Rheumatoid Arthritis Research and Therapies
Papers in
- Epidemiology 16
- Inflammatory Myopathies and Dermatomyositis 14
-
- Systemic Sclerosis and Related Diseases 4
- Co-authors
- João Eurico Fonseca (13 shared papers)Catarina Sousa Guerreiro (3 shared papers)Lorenzo Cavagna (5 shared papers)Jens Schmidt (3 shared papers)Edoardo Conticini (3 shared papers)Nikita Khmelinskii (5 shared papers)Simone Barsotti (3 shared papers)Fernando Saraiva (2 shared papers)
In The Last Decade
Eduardo Dourado
19 papers receiving 179 citations
Peers
Comparison fields: 5 of 52
- Rheumatology 39
- Gastroenterology 8
- Pharmacology 13
- Epidemiology 45
- Immunology 20
Countries citing papers authored by Eduardo Dourado
This map shows the geographic impact of Eduardo Dourado's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eduardo Dourado with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eduardo Dourado more than expected).
Fields of papers citing papers by Eduardo Dourado
This network shows the impact of papers produced by Eduardo Dourado. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eduardo Dourado. The network helps show where Eduardo Dourado may publish in the future.
Co-authors
The 25 scholars most cited alongside Eduardo Dourado, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 57 | |
| 2 | 2021 | 46 | |
| 3 | 2023 | 13 | |
| 4 | 2023 | 12 | |
| 5 | 2021 | 9 | |
| 6 | Safety of intra-articular glucocorticoid injections - state of the art. | 2023 | 8 |
| 7 | Clinical characterisation of a multicentre nationwide cohort of patients with antisynthetase syndrome. | 2022 | 8 |
| 8 | 2024 | 7 | |
| 9 | 2023 | 4 | |
| 10 | 2025 | 3 | |
| 11 | 2023 | 3 | |
| 12 | The safety and persistence of intravenous iloprost in systemic sclerosis. | 2022 | 3 |
| 13 | 2025 | 3 | |
| 14 | 2022 | 2 | |
| 15 | 2022 | 2 | |
| 16 | 2024 | 1 | |
| 17 | The role of opioid analgesics in rheumatic disorders: a position paper from the Portuguese Rheumatology Society. | 2021 | 1 |
| 18 | ANCA-associated vasculitis after Pfizer-BioNTech COVID-19 vaccination: two case reports. | 2023 | 1 |
| 19 | 2024 | 1 | |
| 20 | 2025 | 0 |
About Eduardo Dourado
Eduardo Dourado is a scholar working on Epidemiology, Pathology and Forensic Medicine, Dermatology, Pulmonary and Respiratory Medicine and Rheumatology, having authored 29 papers that have together received 184 indexed citations. Recurring topics across this work include Inflammatory Myopathies and Dermatomyositis (14 papers), Systemic Sclerosis and Related Diseases (4 papers), Vasculitis and related conditions (3 papers), Immunodeficiency and Autoimmune Disorders (3 papers), Skin Diseases and Diabetes (3 papers), Peripheral Neuropathies and Disorders (3 papers), Gut microbiota and health (2 papers) and Muscle and Compartmental Disorders (2 papers). The work is most often cited by research in Rheumatology (39 citations), Gastroenterology (8 citations), Pharmacology (13 citations), Epidemiology (45 citations) and Immunology (20 citations). Eduardo Dourado has collaborated with scholars based in Portugal, Italy and Germany. Frequent co-authors include João Eurico Fonseca, Catarina Sousa Guerreiro, Lorenzo Cavagna, Jens Schmidt, Edoardo Conticini, Nikita Khmelinskii, Simone Barsotti, Fernando Saraiva, Cristina Ponte and Linda Carli. Their work appears in journals such as Clinical and Experimental Rheumatology, Lara D. Veeken, Journal of Clinical Medicine, Nutrients and Arthritis Research & Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.